Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure.
Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure.
复制标题
DOI:
10.7150/ijms.8083
复制
发表时间:
2014
影响因子:
3.6
通讯作者:
Lin YH
中科院分区:
文献类型:
--
作者:
Chang YY;Chen A;Wu XM;Hsu TP;Liu LY;Chen YH;Wu YW;Lin HJ;Hsu RB;Lee CM;Wang SS;Lo MT;Chen MF;Lin YH
Background: Galectin-3 (Gal-3) shows the ability of survival prediction in heart failure (HF) patients. However, Gal-3 is strongly associated with serum markers of cardiac extracellular matrix (ECM) turnover. The aim of this study is to compare the impact of Gal-3 and serum markers of cardiac ECM turnover on prognostic prediction of chronic systolic HF patients. Methods: Serum Gal-3, brain natriuretic peptide (BNP), extracellular matrix including type I and III aminoterminal propeptide of procollagen (PINP and PIIINP), matrix metalloproteinase-2, 9 (MMP-2, 9), and tissue inhibitor of metalloproteinase-1 (TIMP-1) were analyzed. Cox regression analysis was used for survival analysis. Results: A total of 105 (81 male) patients were enrolled. During 980±346 days follow-up, 17 patients died and 36 episodes of HF admission happened. Mortality of these patients was significantly associated with the log PIIINP (β= 15.380; P=0.042), log TIMP-1(β= 44.530; P=0.003), log MMP-2 (β= 554.336; P<0.001), log BNP (β= 28.273; P=0.034). Log Gal-3 (β= 7.484; P=0.066) is borderline associated with mortality. Mortality or first HF admission of these patients was significantly associated with the log TIMP-1(β= 16.496; P=0.006), log MMP-2 (β= 221.864; P<0.001), log BNP (β= 5.999; P=0.034). Log Gal-3 (β= 4.486; P=0.095) only showed borderline significance. In several models adjusting clinical parameters, log MMP-2 was significantly associated with clinical outcome. In contrast, log Gal-3 was not. Conclusion: The prognostic strength of MMP-2 to clinical outcome prediction in HF patients is stronger than Gal-3.
登录
查看更多内容
影响因子:
6.8
作者:
Lin, Yen-Hung;Lin, Chen;Peng, Chung-Kang
通讯作者:
Peng, Chung-Kang
影响因子:
6
作者:
Reifenberg, Kurt;Lehr, Hans-Anton;Loehler, Juergen
通讯作者:
Loehler, Juergen
影响因子:
3.2
作者:
Bujak, Marcin;Frangogiannis, Nikolaos G.
通讯作者:
Frangogiannis, Nikolaos G.
影响因子:
3
作者:
Ochieng, J;Furtak, V;Lukyanov, P
通讯作者:
Lukyanov, P
影响因子:
9.3
作者:
Grandin, E. Wilson;Jarolim, Petr;Morrow, David A.
通讯作者:
Morrow, David A.